Knee pain caused by osteoarthritis is suffered by millions of people worldwide10. TriVisc*, a 3-injection Hyaluronic Acid , may help relieve OA-related knee pain in patients who are unresponsive to non-pharmacologic therapy and simple analgesics.

Reimbursement Code J7329

OA knee pain


  • Highly purified HA produced by bacterial biofermentation technology
  • Removes the risk of avian allergies and sensitivities
  • Safe for repeat injection cycles
  • Fully automated manufacturing process reduces the risk of contamination and human error


  • 35 million doses administered worldwide12†
  • TriVisc* efficacy established by equivalence to Visco-3 ®13
  • Visco-3 determined to be non-inferior to Euflexxa®14
  • Supported by published clinical data
  • TriVisc* exhibited improvement in WOMAC, and VAS scores compared to baseline15,16,17

TriVisc* Product Resources

Links to open new windows with PDFs:

$ Full Prescribing and Safety Information
$ Billing and Coding Guide
$ TriVisc* Physician Brochure

35 Million doses administrated worldwide.18